EYEBIOTECH LIMITED
Ownership resolves 14 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Registry identity
- Status
- active
- Incorporated
- 2021-07-09
- Legal form
- ltd
- Activity
- 72110
- Registered office
- 120 Moorgate, London, EC2M 6UR, England
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- EYEBIOTECH LIMITED
None in current sources.
14-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on EYEBIOTECH LIMITED, resolved and sourced — yours to keep, no subscription.
- UBO trace
- same-address
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace · same-address
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
- Full ownership trace to the UBOSTANDARD
- Cross-source resolution & same-addressSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
Also at this address
Shared registered officeOther companies registered at the same address — a common structuring / formation-agent signal, not proof of a link.
8 other companies at this registered office — unlock the itemised list.
Register record, filings & financials
live · Companies House- Company no.
- 13503296
- Status
- active
- Type
- ltd
- Incorporated
- 2021-07-09
- Registered office
- 120 Moorgate, London, EC2M 6UR, England
- SIC
- 72110
People & control
16 parties · 4 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- LUCAS, Benjamin Paul
- director · British · appointed 2024-07-11 · Companies House
- Merck & Co., Inc.
- corporate PSC · 75–100% shares · United States · since 2024-07-11 · CH · PSC register
Also holds roles at 1 other company- VERONA PHARMA LIMITEDbeneficial owner
- O'SHAUGHNESSY, Peter James
- director · British · appointed 2026-07-01 · Companies House
- ROGERS, Martin Ian
- director · British · appointed 2024-07-11 · Companies House
- ADAMIS, Anthony Peter
- director · American · appointed 2021-08-27 · resigned · Companies House
- AKKARAJU, Srinivas, Dr
- director · American · appointed 2022-02-03 · resigned · Companies House
- BINGHAM, Catherine Elizabeth, Dame
- director · British · appointed 2021-07-09 · resigned · Companies House
- CAN TEMUCIN, Ebru
- director · Turkish · appointed 2024-07-11 · resigned · Companies House
- COSTINE, James Allister John
- director · British · appointed 2021-07-09 · resigned · Companies House
- DAVITIAN, Bernard Thomas
- director · French · appointed 2023-10-13 · resigned · Companies House
- GUYER, David R, Dr
- director · American · appointed 2021-08-02 · resigned · Companies House
- HARRISON, Evelyn Melinda
- director · American · appointed 2022-04-05 · resigned · Companies House
- ROSS, Michael Jay
- director · American · appointed 2021-08-02 · resigned · Companies House
- SV7 (IMF) GP LLPAlso holds roles at 5 other companies
- MESTAG THERAPEUTICS LTDbeneficial owner
- SV HEALTH INVESTORS UK LIMITEDbeneficial owner
- ALCHEMAB THERAPEUTICS LTDbeneficial owner
- Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp
- corporate PSC · 25–50% shares · United Kingdom · ceased 2023-10-13 · CH · PSC register
- corporate PSC · 75–100% shares · United Kingdom · ceased 2022-02-03 · CH · PSC register
- WALLNOFER, Andreas, Dr
- director · Swiss · appointed 2022-02-03 · resigned · Companies House
16 parties · 4 current. Ceased and resigned records are retained as history.